Related references
Note: Only part of the references are listed.Endothelial Progenitor Cells and Cardiovascular Events in Patients with Chronic Kidney Disease - a Prospective Follow-Up Study
Johan Lorenzen et al.
PLOS ONE (2010)
The effect of levodopa treatment on cerebral hemodynamics in patients with Parkinson's disease: Serial transcranial Doppler studies
Seok Woo Yong et al.
PARKINSONISM & RELATED DISORDERS (2010)
Homocysteine reduces endothelial progenitor cells in stroke patients through apoptosis
Mohammad Murshedul Alam et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2009)
Parkinson disease and comorbid cerebrovascular disease
Wandana Nanhoe-Mahabier et al.
NATURE REVIEWS NEUROLOGY (2009)
Circulating Endothelial Progenitor Cells and Age-Related White Matter Changes
Glen Jickling et al.
STROKE (2009)
Endothelial progenitor cell research in stroke - A potential shift in pathophysiological and therapeutical concepts
Rob P. W. Rouhl et al.
STROKE (2008)
Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals
Mervin C. Yoder et al.
BLOOD (2007)
Reduced number and activity of circulating endothelial progenitor cells from patients with hyperhomocysteinemia
JH Zhu et al.
ARCHIVES OF MEDICAL RESEARCH (2006)
Circulating endothelial progenitor cells and cardiovascular outcomes
N Werner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Reduced plasma homocysteine levels in levodopa/entacapone treated Parkinson patients
P Valkovic et al.
PARKINSONISM & RELATED DISORDERS (2005)
Isolation of endothelial progenitor cells from cord blood and induction of differentiation by Ex vivo expansion
JW Shin et al.
YONSEI MEDICAL JOURNAL (2005)
Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells
DA Ingram et al.
BLOOD (2005)
Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients
P Lamberti et al.
MOVEMENT DISORDERS (2005)
Effects of homocysteine on number and activity of endothelial progenitor cells from peripheral blood
JZ Chen et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)
Homocysteine and levodopa - Should Parkinson disease patients receive preventative therapy?
RB Postuma et al.
NEUROLOGY (2004)
Levodopa-associated increase of homocysteine levels and sural axonal neurodegeneration
T Müller et al.
ARCHIVES OF NEUROLOGY (2004)
Hypertrophy of IMC of carotid artery in Parkinson's disease is associated with L-DOPA, homocysteine, and MTHFR genotype
K Nakaso et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2003)
Circulating endothelial progenitor cells, vascular function, and cardiovascular risk
JM Hill et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Elevated plasma homocysteine levels in patients treated with levodopa - Association with vascular disease
JD Rogers et al.
ARCHIVES OF NEUROLOGY (2003)
Fundamentals of endothelial function for the clinical cardiologist
S Verma et al.
CIRCULATION (2002)
Homocysteine and neurologic disease
R Diaz-Arrastia
ARCHIVES OF NEUROLOGY (2000)
Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review
Evita Evangelia Christou et al.
SEMINARS IN OPHTHALMOLOGY
Share Paper
